The major growth driver in the hemodialysis and peritoneal dialysis market is the rising number of patient suffering from high blood pressure and diabetes. The significant prevalence of chronic kidney diseases and growing aging population are other factors contributing towards the continuous growth of hemodialysis and peritoneal dialysis market. Moreover, evolution of new dialysis methods (such as nocturnal dialysis and home hemodialysis) in developing countries such as India and China, among others presents a lucrative growth opportunity for the market players in coming years.

The role of healthy kidney in the human body is to clean blood and remove extra fluids in the form of urine. The requirement for dialysis arises when the kidney is not able to filter extra waste fluids from the body. The dialysis treatment consists of two types of procedures; hemodialysis and peritoneal dialysis.

Geographically, North America held the largest share of the market in 2017. The growth in the region is mainly attributed to the high prevalence of diabetes and hypertension patients coupled with the adoption of new technologies. Moreover, growing number of dialysis centers and increasing awareness regarding the availability of various treatment options are further boosting the market growth in the region. Europe held the second largest share of the market in 2017. The growth in the region is attributed to the higher incidence of chronic kidney diseases, new product innovations, and growing number of patients suffering from diabetes and hypertension. Moreover, rising prevalence of end-stage renal diseases and growing aging population is further propelling the market growth in the region. Asia-Pacific held the third largest share of the market and is expected to witness the highest CAGR during the forecast period due to increasing awareness regarding kidney diseases, shortage of kidney donors and growing investments in research and development activities in the region.

Some of the key companies operating in the market include Fresenius Medical Care AG & Co. KGaA, Integer Holdings Corporation, Nxstage Medical, Inc., Allmed Medical Care Holdings Limited, Davita Healthcare Partners Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Diaverum Deutschland GmbH, Baxter International Inc., B. Braun Melsungen AG, and Nikkiso Co., Ltd., among others

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Global Hemodialysis and Peritoneal Dialysis- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global hemodialysis and peritoneal dialysis market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Increasing investment in research and development

3.5.2. Growing number of dialysis centers across the globe

3.5.3. Growing awareness of CKD and treatment options

3.6. Market dynamics

3.6.1. Market driver analysis

           3.6.1.1. Increasing number of patients diagnosed with end-stage renal disease

   3.6.1.2. Growing number of patients suffering from diabetes and high blood pressure

   3.6.1.3. Shortage of kidney donors

   3.6.1.4. Favorable healthcare insurance policies

   3.6.1.5. Technological advancements and novel product innovations

3.6.2. Market restraint analysis

    3.6.2.1. Stringent government regulations

    3.6.2.2. Product recalls

3.6.3. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.2. Competitive factors

4.3. Company market share analysis

4.4. Strategies adopted

CHAPTER 5. Global Hemodialysis and Peritoneal Dialysis Market Size and Forecast (2014 – 2024)

5.1. Global Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

5.1.1. Hemodialysis

  5.1.1.1. Conventional Hemodialysis

  5.1.1.2. Short Daily Hemodialysis

  5.1.1.3. Nocturnal Hemodialysis

       5.1.2. Peritoneal Dialysis

          5.1.2.1. Continuous Ambulatory Peritoneal Dialysis (CAPD)

          5.1.2.2. Automated Peritoneal Dialysis (APD)

5.2. Global Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

5.2.1. Device

   5.2.1.1. Machine

          5.2.1.1.1. Center-Use Hemodialysis Machines

          5.2.1.1.2. Home-Use Hemodialysis Machines

   5.2.1.2. Dialyzer

         5.2.1.2.1. Flux Type

                  5.2.1.2.1.1. High-Flux Dialyzers

                  5.2.1.2.1.2. Low-Flux Dialyzers

         5.2.1.2.2. Material Type

   5.2.1.2.2.1. Synthetic Dialyzers

   5.2.1.2.2.2. Cellulose-Based Dialyzers

   5.2.1.3. Water Treatment System

          5.2.1.3.1. Central Water Disinfection Systems

          5.2.1.3.2. Portable Water Disinfection Systems

    5.2.1.4. Others

      5.2.2. Consumables

   5.2.2.1. Bloodline

   5.2.2.2. Concentrates

                   5.2.2.2.1. Acidic

                   5.2.2.2.2. Alkaline

    5.2.2.3. Catheters

    5.2.2.4. Others

         5.2.3. Service

    5.3. Global Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

     5.3.1. Dialysis centers & hospital-based dialysis

     5.3.2. Home-based Dialysis

CHAPTER 6. Global Hemodialysis and Peritoneal Dialysis Market Size and Forecast, By Geography (2014-2024)

6.1. North America Hemodialysis and Peritoneal Dialysis Market

6.1.1. North America Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

6.1.2. North America Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

6.1.3. North America Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

6.1.4. North America Hemodialysis and Peritoneal Dialysis Market, By Country (USD Billion)

   6.1.4.1. US

   6.1.4.2. Canada

   6.1.4.3. Mexico

6.2. Europe Hemodialysis and Peritoneal Dialysis Market

6.2.1. Europe Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

6.2.2. Europe Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

6.2.3. Europe Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

6.2.4. Europe Tube Market, By Country (USD Billion)

   6.2.4.1. Spain

   6.2.4.2. France

   6.2.4.3. Italy

   6.2.4.4. UK

   6.2.4.5. Germany

   6.2.4.6. Austria

   6.2.4.7. Russia

   6.2.4.8. Rest of Europe

6.3. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market

6.3.1. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

6.3.2. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

6.3.3. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

6.3.4. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market, By Country (USD Billion)

   6.3.4.1. Japan

   6.3.4.2. China

   6.3.4.3. India

   6.3.4.4. South Korea

   6.3.4.5. Australia

   6.3.4.6. Rest of Asia-Pacific

6.4. Central & South America Hemodialysis and Peritoneal Dialysis Market

6.4.1. Central & South America Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

6.4.2. Central & South America Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

6.4.3. Central & South America Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

6.4.4. Central & South America Hemodialysis and Peritoneal Dialysis Market, By Country (USD Billion)

    6.4.4.1. Brazil

    6.4.4.2. Rest of Central & South America

6.5. Middle East and Africa (MEA) Hemodialysis and Peritoneal Dialysis Market

6.5.1. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market, By Type (USD Billion)

6.5.2. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market, By Product (USD Billion)

6.5.3. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market, By End-use (USD Billion)

6.5.4. Middle East and Africa Hemodialysis and Peritoneal Dialysis Market, By Country (USD Billion)

   6.5.4.1. Saudi Arabia

   6.5.4.2. UAE

   6.5.4.3. Israel

   6.5.4.4. South Africa

   6.5.4.5. Iran

   6.5.4.6. Rest of MEA

CHAPTER 7. Key Players and Strategic Developments

7.1. Fresenius Medical Care AG & Co. KGaA

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Integer Holdings Corporation

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Nxstage Medical, Inc.

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Allmed Medical Care Holdings Limited

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Davita Healthcare Partners Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Asahi Kasei Medical Co., Ltd.

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Nipro Corporation

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Diaverum Deutschland GmbH

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Baxter International Inc.

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. B. Braun Melsungen AG

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Nikkiso Co., Ltd.

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments